Skip to content
Baltimore News Journal – Lifestyle
Author:
Apotex Inc.
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
←
Previous Page
1
2